Avalo Therapeutics (AVTX) News Today $10.90 -0.15 (-1.36%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Avalo Therapeutics receives $69.4M in proceeds from exercise of warrantsNovember 12, 2024 | markets.businessinsider.comAvalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement WarrantsNovember 12, 2024 | globenewswire.comAvalo Therapeutics to Present at Upcoming Investor ConferencesNovember 11, 2024 | globenewswire.comOppenheimer Remains a Buy on Avalo Therapeutics (AVTX)November 9, 2024 | markets.businessinsider.comAvalo Therapeutics (AVTX) Receives a Hold from H.C. WainwrightNovember 9, 2024 | markets.businessinsider.comAvalo Reports Third Quarter 2024 Financial Results and Recent Business UpdatesNovember 7, 2024 | finance.yahoo.comHC Wainwright & Co. Initiates Coverage of Avalo Therapeutics (AVTX) with Neutral RecommendationOctober 24, 2024 | msn.comAvalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis SuppurativaOctober 8, 2024 | globenewswire.comAvalo Therapeutics (NASDAQ:AVTX) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comAvalo Therapeutics (NASDAQ:AVTX) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comAvalo Therapeutics Inc. (C6K0.SG)September 19, 2024 | uk.finance.yahoo.comAvalo Announces Participation in September Investor ConferencesSeptember 4, 2024 | finance.yahoo.comThe 3 Best Personalized Nutrition Stocks to Buy NowJuly 24, 2024 | investorplace.comAvalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical OfficerJuly 16, 2024 | globenewswire.comAvalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis SuppurativaJuly 9, 2024 | globenewswire.comAvalo Therapeutics Announces Appointment of Paul Varki as Chief Legal OfficerJune 24, 2024 | globenewswire.comAvalo to Present at the Oppenheimer Novel Targets in Immunology SummitJune 17, 2024 | globenewswire.comAVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024May 13, 2024 | investorplace.comAvalo Therapeutics: Avalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 13, 2024 | finanznachrichten.deAvalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 13, 2024 | globenewswire.comOppenheimer Upgrades Avalo Therapeutics (AVTX)April 17, 2024 | msn.comAvalo Therapeutics (AVTX) Price Target Increased by 4566.67% to 35.70April 17, 2024 | msn.comWhy VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving PremarketApril 2, 2024 | benzinga.comAvalo Therapeutics Appoints Biotech Leaders to Board of DirectorsApril 2, 2024 | globenewswire.comAvalo Therapeutics Shares More than Triple After Co Acquires AlmataBioMarch 29, 2024 | marketwatch.comAvalo Reports 2023 Financial Results and Provides Business UpdatesMarch 29, 2024 | globenewswire.comAvalo Therapeutics: Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 MillionMarch 29, 2024 | finanznachrichten.deTrading was temporarily halted for "AVTX" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 04:03 PM. March 28, 2024 | marketbeat.comMicro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin DisorderMarch 28, 2024 | msn.comTrading was temporarily halted for "AVTX" at 09:03 AM with a stated reason of "LULD pause."March 28, 2024 | marketbeat.comWhy Is Avalo Therapeutics (AVTX) Stock Up 326% Today?March 28, 2024 | investorplace.comAvalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 MillionMarch 27, 2024 | globenewswire.comAvalo (AVTX) to Report Q4 Earnings: What's in the Cards?February 26, 2024 | finance.yahoo.comAvalo Therapeutics Stock (NASDAQ:AVTX) Dividends: History, Yield and DatesJanuary 2, 2024 | benzinga.comTrading was temporarily halted for "AVTX" at 07:12 PM with a stated reason of "News pending."December 29, 2023 | marketbeat.comAvalo Therapeutics announces a 1-for-240 reverse stock splitDecember 27, 2023 | msn.comAvalo Therapeutics Announces 1-for-240 Reverse Stock SplitDecember 27, 2023 | finance.yahoo.comAvalo Therapeutics, Inc. (AVTX) stock forecast and price targetDecember 18, 2023 | finance.yahoo.comAvalo Therapeutics: Avalo Encourages Stockholders to Vote FOR the Reverse Stock SplitDecember 7, 2023 | finanznachrichten.deAvalo Encourages Stockholders to Vote FOR the Reverse Stock SplitDecember 7, 2023 | finance.yahoo.comAvalo Therapeutics Stock (NASDAQ:AVTX) Earnings Dates and Earning CallsNovember 11, 2023 | benzinga.comAvalo Therapeutics Inc AVTXNovember 9, 2023 | morningstar.comAvalo Therapeutics Inc (AVTX) Announces Q3 2023 Financial Results and Strategic AdvancesNovember 9, 2023 | finance.yahoo.comAvalo Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNovember 9, 2023 | finance.yahoo.comAvalo Completes Divestiture of AVTX-800 SeriesOctober 31, 2023 | finance.yahoo.comBestGrowthStocks.com Issues a Comprehensive Analysis of Avalo TherapeuticsSeptember 27, 2023 | finance.yahoo.comWhy Avalo Therapeutics Stock Is Up TodaySeptember 26, 2023 | benzinga.comWhat's Going On With Avalo Therapeutics (AVTX) Stock?September 22, 2023 | benzinga.comWhy Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving PremarketSeptember 18, 2023 | benzinga.comWhy Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionSeptember 13, 2023 | benzinga.com Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. AVTX Media Mentions By Week AVTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVTX News Sentiment▼1.000.45▲Average Medical News Sentiment AVTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVTX Articles This Week▼10▲AVTX Articles Average Week Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Assembly Biosciences News Today Candel Therapeutics News Today aTyr Pharma News Today OncoCyte News Today DURECT News Today GlycoMimetics News Today Sol-Gel Technologies News Today Lexicon Pharmaceuticals News Today UroGen Pharma News Today Xeris Biopharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTX Stock Alerts